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ABSTRACT 
THE ROLE OF PROTEIN KINASE A IN HYPOXIA-INDUCED 
PC-12 CELL DEATH 
Cynthia Jayne Miller 
July 1, 2008 
Hypoxia is characterized by an inadequate oxygen supply to the tissues in 
proportion to their metabolic needs, and is a primary factor in traumatic CNS 
injury, strokes, cardiopulmonary diseases, and obstructive sleep apnea. The 
cAMP-dependent protein kinase (PKA) has been attributed a role as an anti-
apoptotic kinase as well as a pro-apoptotic signal. Thus the role of PKA in 
hypoxia-induced cell survival is currently unclear. 
We show here that hypoxia induces cell death in WT PC-12 cells, 
pheochromocytoma cells used as a model of the oxygen-sensitive carotid body 
glomus cells. The onset of cell death following 24 hours of severe, sustained 
hypoxia also correlated with an increase in oxidative stress and a drop in ATP 
levels. Inactivation of PKA in the 123.7 PC-12 cell line prevented the hypoxia-
induced ROS surge, energy depletion, and cell death. PKA activity thus 
contributes to hypoxia~induced cell death in WT cells via enhanced ROS 
production and energy depletion, but was not shown to playa role in the 
regulation of cellular antioxidant mechanisms. 
iv 
123.7 cells had lower levels of hypoxia-induced glucose utilization and 
lactate release than WT cells, thus PKA appears to stimulate increases in 
glycolytic flux during hypoxia. Mitochondrial potentials were higher in 123.7 
cells than in WT cells, indicating that PKA inhibits mitochondrial metabolism. 
Furthermore, the expression of COX IV was decreased by hypoxic exposure in 
both cell types, but was significantly greater in 123.7 cells. The greater 
expression of COX IV may allow 123.7 cells to maintain mitochondrial electron 
flow and energy production under drastically reduced oxygen conditions. 
Antioxidant treatment blocked hypoxia-induced cell death, but was not 
sufficient to prevent depletion of ATP or to modulate the metabolic pathways. 
Thus, this finding indicates that hypoxia-induced metabolic regulation and energy 
depletion occur independently of oxidative stress. 
Consequently, the PKA signaling pathway appears to contribute to 
hypoxia-induced cell death through its regulatory effects on oxidative stress and 
metabolic pathways. Modulation of the PKA signaling pathway could provide 
novel therapeutic strategies to improve cellular adaptation and recovery in the 
many pathologies characterized by periods of hypoxia. 
v 
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INTRODUCTION 
Hypoxia is characterized by an inadequate oxygen supply to the tissues 
in proportion to their metabolic need and can result from a number of conditions 
that cause defective oxygen uptake at the lungs, or insufficient transport of 
oxygen-rich blood to the tissues. Hypoxia is a primary factor in traumatic eNS 
injury, strokes, cardiopulmonary diseases, and obstructive sleep apnea (OSA). 
Strokes, resulting from severe hypoxic events, are among the most prevalent 
causes of death nationwide, (1) while OSA affects 2-5% of the population in the 
United States (2). 
It has been previously reported that hypoxia induces apoptosis and that 
the extent of the apoptotic response is critically dependent on the severity and 
the duration of the hypoxic injury (3). Hypoxia induces gene transcription by 
cooperative activation of several transcription factors, notably NF-KB, AP-1 and 
the hypoxia-inducible HIF-1a (4,5,6,7). Thus, an understanding of the 
mechanisms underlying cellular survival to hypoxia may provide novel therapies 
to improve cellular outcome of hypoxia/ischemia and some neurodegenerative 
pathologies. 
When cells are exposed to hypoxia, there is a shift in cellular metabolism 
(Figure 1) from aerobic, mitochondrial energy production to anaerobic glycolytic 
1 
processes. In the process of glycolysis, cells harness the energy of the 
carbohydrate glucose in a series of cytoplasmic enzymatic reactions, resulting in 
a net production of two pyruvate, two ATP, and two NADH molecules. In the 
presence of oxygen, pyruvate is converted in a transition reaction to acetyl CoA, 
producing two additional molecules of NADH. Acetyl CoA then enters a series of 
enzymatic reactions in the mitochondria known as the Krebs Cycle, resulting in 
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Figure 1: Mitochondrial Metabolism. Under normoxic conditions 
energy is produced via both glycolysis and aerobic, mitochondrial 
pathways. However, under hypoxic states, aerobic metabolism is 
decreased and cells must rely on glycolysis for energy production_ 
2 
, 
Cytoplasmic NADH from glycolysis can be transported in the mitochondria 
using either the glycerophosphate shuttle or the malate-aspartate shuttle, 
producing FADH2 or NADH, respectively, on the matrix side of the inner 
mitochondrial membrane. The reduced compounds derived from glycolysis and 
the Krebs Cycle then donate electrons to a series of redox carriers in the 
mitochondria known as the electron transport chain. At complex IV, cytochrome 
oxidase, the electrons are used to reduce 02 to H20. 
The movement of electrons through the chain to more positive redox 
potentials results in the formation of energy, harnessed in the form of a proton 
gradient. The movement of protons back down their electrochemical gradient 
across the inner mitochondrial membrane is used to produce ATP via the 
enzyme ATP synthase. Under aerobic conditions, one molecule of glucose can 
produce 36-38 ATP, depending on the NADH shuttle system utilized. 
However, during hypoxia, oxygen-dependent oxidative phosphorylation 
processes decline and cells must progressively rely on anaerobic metabolism. 
Hypoxia has been shown in PC-12 cells to decrease the activity of enzymes 
involved in oxidative phosphorylation, including Complexes I, II, and IV of the 
electron transport chain (8). Furthermore, hypoxic upregulation of glycolytic 
enzymes, such as hexokinase and phosphofructokinase, has been shown in PC-
12 cells (8). This decreased oxidative phosphorylation can present a significant 
problem in energy homeostasis, since glycolysis produces a net gain of only 2 
ATP relative to the approximately 38 ATP that can be produced by oxidative 
phosphorylation and glycolytic processes combined. 
3 
Mitochondria contain a large number of redox carriers, such as those of 
the mitochondrial electron transport chain, that are capable of leaking electrons. 
Under physiological cellular conditions, some of these electrons slip away from 
their oxidative pathways to oxygen and produce superoxide anion, a progenitor 
reactive oxygen species (ROS). In resting cells, approximately 1-2% of the 
electrons passing through the electron transport chain undergo this process, 
resulting in a significant basal production of ROS (9). It is believed that 
Complexes I and III of the electron transport chain are the primary sites of 
superoxide production (10). Mitochondria are thus particularly susceptible to 
oxidative injury due to their constant generation and close proximity to the short-
lived ROS. Furthermore, mitochondrial DNA is prone to oxidative injury because 
it lacks the protection of histone proteins, and mitochondrial DNA polymerases 
are highly susceptible to ROS damage (11). 
While a certain basal level of ROS appear to be required for proper cell 
function (12), dysregulation may result in overproduction of superoxide anion and 
increased formation of toxic ROS. Consequently, cells have elaborate defense 
systems in place to counteract the production of ROS. It is only once these 
defense systems become overwhelmed that oxidative stress ensues. 
Many primary defense mechanisms exist to neutralize reactive oxygen 
species before they inflict damage on cellular structures. These include enzymes 
such as superoxide dismutase, catalase, and glutathione peroxidase. 
Superoxide dismutase (SOD) catalyzes the conversion of the superoxide free 
radical into another ROS, hydrogen peroxide. Hydrogen peroxide can then be 
4 
converted to water and oxygen by the enzymes catalase or glutathione 
peroxidase. Catalase, which is present only in 
peroxisomes, is a highly efficient, unsaturable enzyme 
H20 2 H20 
~ under physiological conditions. The tripeptide glutathione Glutathione Peroxidase 
(y-Glu-Cys-Gly), which is present in both the cytosol and ~ 
GSH GSSG 
mitochondria, makes up one of the main cellular ~ 
antioxidant defenses and detoxification pathways (Figure Gluthathione Reductase 
~2). 
In an unstressed cell, glutathione 
redox balance is achieved by the 
maintenance of the GSH (reduced)/GSSG 
(oxidized) glutathione ratio. This balance is 
NADP+ NADPH 
Figure 2: Glutathione Redox 
Cycle. The reduced form of 
glutathione (GSH) detoxifies 
hydrogen peroxide. NADPH is 
used to regenerate GSH from 
its oxidized form. 
tightly regulated by the availability of NADPH, which is required to regenerate 
GSH from its oxidized GSSG form in the glutathione redox cycle. Upon oxidant 
stress, GSH will react with ROS and GSSG will increase, decreasing the 
GSH/GSSG ratio. Therefore, measurements of cellular GSH/GSSG and NADPH 
can be used as indicators of cellular redox status. 
Low oxygen availability may perturb the mitochondrial electron transfer 
chain, resulting in increased ROS and disruption of cellular energy balance (13). 
In cardiomyocytes and hepatocytes, hypoxia decreases Vmax of the rate limiting, 
oxygen-dependent enzyme of the mitochondrial respiratory chain, cytochrome 
oxidase (COX IV) (14,15). COX IV is the terminal electron acceptor in the 
mitochondrial electron transport chain which converts molecular oxygen (02) to 
5 
water. COX IV consists of 13 subunits, 3 of which (subunits I, II, and II) are 
encoded by mitochondrial DNA and synthesized directly in the mitochondria (8). 
The other 10 subunits of cytochrome oxidase (IV, Vb, Via, Vlb, Vic, VilA, Vllb, 
and VIII) are synthesized in the cytosol by the nuclear genome, and then 
transported into the mitochondria (8). 
Hypoxia has been shown to decrease the activity of COX IV in rat 





Figure 3: Effect of Hypoxia on Reactive 
Oxygen Species Generation in the Electron 
Transport Chain. Hypoxia decreases the 
activity of Complex 4 of the mitochondrial 
electron transport chain, leading to an increased 
production of superoxide anion, a progenitor 
reactive oxygen species. 
complex could produce 
a "trafficking" problem 
through the electron 
transport chain, 
resulting in an 
increased slippage of 
electrons away from 
their normal movement 
through the chain, and 
increased production of 
ROS (Figure 3). This 
process could potentially 
overwhelm the antioxidant 
capabilities of the cell, leading to oxidative stress, and cellular death. 
Protein Kinase A (PKA) signaling may affect multiple mitochondrial chain 
enzymes. PKA has been shown in mouse fibroblasts to directly phosphorylate 
6 
an 18kDA subunit of complex I of the mitochondrial electron transport chain, 
resulting in an increase in its activity (16). Furthermore, PKA has been shown to 
phosphorylate subunits I, IV, and Vb of complex IV of the mitochondrial electron 
transport chain. In vitro phosphorylation of COX IV by PKA in bovine heart and 
rat macro phages decreases its activity by 40-70% (17). Furthermore, the Ria 
regulatory subunit of PKA directly binds to the Vb subunit of COX IV and inhibits 
its activity (18). All of these PKA-mediated effects could potentially increase the 
leakage of electrons away from the mitochondrial electron transport chain , and 
shift the redox balance of the cell towards a state of oxidative stress. Indeed, it 
has been shown in rat macrophages that PKA phosphorylation of COX IV under 
••• . ---.. 
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Figure 4: Protein Kinase A Activation. 
hypoxic conditions leads to a 
decrease in COX IV activity and 
generation of excess ROS (17). 
Furthermore, in the rabbit heart, 
inhibitors of PKA were shown to 
have protective effects against 
ischemia-reperfusion injury (17). 
The ubiquitously 
cAMP binds to the regulatory subunits of expressed cAMP-dependent 
PKA, inducing a conformation change 
that allows the catalytic subunits to protein kinase (PKA) is a 
dissociate and phosphorylate PKA 
substrates. tetramer consisting of two 
regulatory subunits and two catalytic subunits (Figure 4) (19). Upon stimulation, 
cAMP is increased and binds to the regulatory subunits, inducing the release of 
7 
the catalytic subunits to phosphorylate PKA substrates. Intracellular cAMP levels 
are maintained through a G-protein signaling cascade regulating the enzyme 
adenylate cyclase. The binding of an extracellular ligand to a G-protein coupled 
receptor facilitates the dissociation of the heterotrimeric G-protein. Upon 
stimulation, the a-subunit binds GTP and dissociates from the ~-y subunit. The 
activated a-subunit is then able to modulate the activity of adenylate cyclase. 
Activation of the stimulatory G protein cascade (Gs ) increases adenylate 
cyclase activity and cAMP production, while stimulation of the inhibitory G protein 
(Gi) inhibits adenylate cyclase and decreases cAMP levels. Under basal 
conditions, cAMP concentrations are kept at a low level of around 10-7 M (19). 
However, upon stimulation cAMP levels can rise over twenty fold (19). cAMP 
levels are thus carefully regulated in cells through an intricate process of 
formation by adenylate cyclase and degradation via cAMP phosphodiesterase. 
Activity of cAMP phosphodiesterase is essential for the maintenance of localized 
cAMP gradients and compartmentalization of PKA signaling (20,21). 
cAMP binds to PKA in a positive cooperative manner, allowing the 
dissociation of the catalytic subunits to phosphorylate intracellular substrates. 
One of the most studied PKA cellular targets is the ubiquitously expressed 
transcription factor, cAMP response element binding protein (CREB). PKA 
phosphorylates CREB at a single serine residue (22), resulting in its activation. 
CREB then recruits a transcriptional activator, the CREB binding protein (CBP), 
and binds to the cAMP response element (CRE) producing alteration in gene 
8 
expression. Therefore, PKA is essential to the transcriptional control of a wide 
variety of CREB-driven genes. 
Although several isofonns of PKA have been identified, two main types of 
PKA (PKA I and II) have been described, differing in their regulatory subunit (RI 
and RII), and their relative sensitivity to cAMP levels. RI contains a high affinity 
binding site for Mg-ATP, while RII contains an auto-phosphorylation site (23,24). 
PKA I responds to small, transient alterations in cAMP levels, while PKA II is 
activated by sustained, high cAMP levels (25). It was originally thought that PKA 
I was a cytosolic protein, while PKA II was tethered to specific intracellular 
locations via the A Kinase Anchoring Proteins (AKAPs). However, recent 
evidence identified AKAPs that bind to both isofonns, as well as AKAPs that are 
specific for PKA I (26). AKAPs bind PKA to specific intracellular membranes, 
organelles, or cytoskeletal components, allowing for localization of PKA close to 
its upstream activators and downstream phosphorylation targets. 
PKA activity is also controlled by endogenous protein kinase inhibitor 
peptides (PKls). These heat stable peptides bind to the free catalytiC subunit of 
PKA and inhibit its activity (27). PKls also transports the free catalytiC subunit 
from the nucleus into the cytoplasm, thus diminishing its effects on gene 
transcription (27). 
PKA regulates a wide variety of cellular processes including cert cycle and 
growth, ion fluxes, microtubule dynamics, chromatin condensation, and nuclear 
envelope fonnation (26). It has been attributed a role as an anti-apoptotic kinase 
as well as a pro-apoptotic signal, thus the role of PKA in hypoxia-induced cell 
9 
survival is currently unclear (28,29). It is widely accepted that PKA 
phosphorylates and inhibits the pro-apoptotic protein BAD, and has thus been 
classically defined as an anti-apoptotic kinase. Furthermore, PKA has also been 
shown to bind to the pro-apoptotic p73, phosphorylating and inhibiting the activity 
of this p53 tumor suppressor homolog (30). Activation of PKA has been shown 
to be neuroprotective in a variety of neuronal models (31). This protection may 
be due to PKA phosphorylation and activation of CREB pathways, suppression of 
neuronal Nitric Oxide Synthase (nNOS), and/or inhibition of the IP3 receptor and 
the subsequent drop in calcium release from the endoplasmic reticulum 
(32,33,34 ). 
More recent work suggests that PKA has numerous pro-apoptotic roles in 
the hypoxic response. Consequently, the role of PKA in hypoxia-induced cell 
death may be critically dependent on the severity and duration of the insult. In 
addition to its role in electron transport chain regulation, PKA has been 
implicated in the control of the glycolytic rate limiting enzyme, 
phosphofructokinase, implicating PKA in the regulation of glucose metabolism 
(35,36). PKA-dependent transcription factors are also required for the hypoxia-
inducible factor, HIF-1 a transcriptional activity, necessary for up-regulation of 
glycolytic enzymes and glucose transporters (6,37,38). 
10 
HIF-1 is a heterodimeric protein consisting of a. and ~ subunits (Figure 5). 
While both subunits are constitutively expressed, HIF-1a. undergoes continuous 
Normoxia 
I HIF-1a I I 1 1-- 1 
P P N 
402562803 
Hypoxia 
I H'F-1a l I II 
P P N 
II 11 - c:=!P-DS3 
f f ~ f ~ ~ 
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. HIF-1P . 
/ Adapted from Zagor.;l<a A. Dulak J . HIF-1 : the knowns and unknowns of hypoxia sensing. 
Acta Biochim Pol. 2004;51(3) :56~. 
Figure 5: Regulation of the Hypoxia Inducible Factor 1 
(HIF-1) under Normoxic and Hypoxic Conditions. 
HIF-1a. is constitutively expressed, but under normoxic 
conditions is hydroxylated and degraded by the 
proteosome. Under hypoxic conditions, hydroxylation of 
HIF-1 a. is inhibited and the protein is able to translocate to 
the nucleus and associate with HIF-1~. The dimer then 
binds the Hypoxia Response Element (HRE) and initiates 
gene transcription. 
degradation during normoxic conditions. When oxygen is abundant, HIF-1 a. is 
hydroxylated at Pr0402 and Pro564 by HIF-1 prolyl-4 hydroxylases, targeting the 
protein for degradation. von Hippel-Lindau tumor suppressor proteins (pVHLs) 
bind to the hydroxylated protein residues, and subsequently attract other 
members of the E3 ubiquitin ligase complex. HIF-1 a. is then ubiquitinated and 
degraded by the 265 proteasome. Under hypoxic conditions, the HIF-1 prolyl 
11 
hydroxylases are inactivated through largely unknown mechanisms, and HIF-1a 
is able to escape hydroxylation, ubiquitination, and subsequent degradation. 
The activation of HIF-1a is also regulated by oxygen availability. Under 
normoxic conditions, an Asn803 residue within the C-terminal transactivation 
domain is hydroxylated by the factor inhibiting HIF-1 (FIH-1), and the binding of 
essential coactivators is prevented (39). This hydroxylation is inhibited under 
hypoxic conditions, thus allowing transcriptional activation to proceed. However, 
in order for transcription to occur, HIF-1 a must first translocate to the nucleus, 
where it is able to dimerize with the HIF-1J3 subunit. HIF-1 then binds to the 
hypoxia response element (HRE), allowing the regulation of processes integral to 
oxygen homeostasis. 
While HIF-1a regulates adaptive genes involved in erythropoiesis, 
angiogenesis, glucose and energy metabolism, recent reports also implicate HIF-
1 a in hypoxia-induced cell death after prolonged and severe hypoxia via p53 or 
pro-apoptotic Bcl2-family members-dependent mechanisms (40,41,42). 
Hypoxia-induced ROS, which is believed to be increased by PKA activity, may 
also further activate HIF-1 a, enhancing the cell's transcriptional response to 
hypoxia (43). Consequently, the PKA pathway may have an important role in the 
regulation of metabolic pathways and energy production. 
The rat PC-12 cell line has been widely used as a model of oxygen 
sensitive, neuronal-like cells to study hypoxia-induced signaling (44,45,46). PC-
12 cells closely resemble carotid body type I cells, or glomus cells, 
morphologically and phenotypically (44). Both cell types are excitable, oxygen-
12 
sensitive, and resistant to hypoxia-induced cell death (46). Carotid body glomus 
cells increase their firing rate in response to hypoxia, hypercapnia, and/or 
acidosis. This signal is transmitted via the glossopharyngeal nerve to the dorsal 
respiratory group of the medulla, which stimulates ventilation. 
In PC-12 cells, exposure to hypoxia causes inactivation of an oxygen-
sensitive potassium channel (Shaker KV1.2 K+ channel) leading to a graded 
depolarization of the cell membrane (46). This depolarization opens voltage 
gated calcium channels, producing an influx of calcium into the cell. The 
increase in intracellular calcium leads to a variety of effects, including the 
synthesis and release of neurotransmitters such as dopamine, adenosine, and 
glutamine, and alterations in gene expression (46). Intracellular calcium binds to 
calmodulin, leading to activation of a variety of enzymes, including calmodulin 
kinases and Ca2+ regulated adenylate cyclases. Thus, there is a direct link 
between hypoxia-induced responses and PKA signaling in PC-12 cells. 
In order to examine the effects of PKA activity on hypoxic cell death, I 
used a genetically altered line of PC-12 cells, called 123.7 cells, which have a 
mutated PKA I regulatory subunit. This mutation prevents the binding of cAMP, 
such that the catalytic subunits of PKA can not be released, and only minimal 
PKA activity exists (47). Upon stimulation with 5 fJM of cAMP, 123.7 cells 
displayed only 12% PKA I activity and 16% PKA II activity (47). This suggests 
that RI and RII compete for the same pool of catalytic subunits (47). cAMP is 
unable to bind to RI, preventing the dissociation of the catalytic subunits from the 
mutant PKA I tetramer. PKA I sequesters the catalytic subunits, and prevents 
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their binding to the non-mutated RII subunits. In this manner, mutation of one 
isoform drastically reduces the activity levels of both PKA I and II. The use of the 
123.7 cell line allows elucidation of the contribution of the PKA pathway to 
cellular energy homeostasis and hypoxia-induced oxidative stress. 
Based on the current literature, I hypothesized that PKA activity regulates 
PC-12 hypoxic cell death via oxidative stress and cellular energy depletion. To 
examine this hypothesis, Specific Aim 1 was to determine whether PKA activity 
affects cellular tolerance to hypoxia and production of oxidant species. WT and 
123.7 PC-12 cells were exposed to either normoxic or sustained hypoxic 
conditions for up to 24h. Cellular viability was assessed in each cell line to 
determine (1) whether hypoxia induced cell death in the PC-12 cell line and (2) 
whether PKA activity, which is present in the WT cell line but minimal in the 123.7 
cell line, contributed to this hypoxia-induced cell death. ROS levels were also 
analyzed in WT and 123.7 cells to examine the role of hypoxia and/or PKA 
activity in cellular oxidative stress. However, ROS levels are not only dependent 
on their rate of production, but also on their rate of detoxification by antioxidant 
systems. Therefore, I analyzed the glutathione redox system and expression of 
superoxide dismutase-1 (SOD-1) in WT and 123.7 cells to determine any 
differences in their antioxidant response. 
Specific Aim 2 was to determine whether PKA regulates hypoxia-induced 
cell death via oxidative stress and/or energy depletion. In order to determine the 
effect of PKA on hypoxia-induced energy failure, WT and 123.7 cells were 
exposed to either room air or sustained hypoxia, and ATP levels were analyzed. 
14 
Furthermore, cAMP levels were measured in the two cell lines at both room air 
and hypoxic conditions to determine any differences. In the 123.7 cells, cAMP is 
unable to bind to the regulatory subunits of PKA. This could potentially affect 
cAMP synthesis or degradation and alter cAMP levels within the cells. 
Oxidative stress may contribute to hypoxia-induced PC-12 cell death 
through its effects on energy depletion, or directly through damage to intracellular 
components. WT and 123.7 cells were pre-treated with the antioxidant N-acetyl 
cysteine one hour prior to their hypoxic exposure. ROS levels were analyzed to 
assess the effectiveness of the antioxidant in decreasing oxidative stress, and 
cell survival was analyzed to determine the role of ROS in hypoxia-induced PC-
12 cell death. ATP and cAMP levels were examined following antioxidant 
treatment to establish the role of ROS in hypoxia-induced energy failure. 
PKA has been shown to regulate energy production through its control of 
enzymes in the glycolytic pathway and the mitochondrial electron transport chain. 
Thus for Specific Aim 3, I wanted to determine whether PKA affects cellular 
energetic status through regulation of metabolic pathways. In particular, it was 
important to determine (1) whether PKA plays a role in regulation of 
mitochondrial function and (2) whether PKA activity has an effect on glycolytic 
flux. An antioxidant was used to determine whether hypoxia-induced oxidative 
stress directly regulates the metabolic pathways. Mitochondrial function of WT 
and 123.7 cells was assessed through the expression of cytochrome oxidase, 
and measurement of the mitochondrial membrane potential. Glycolytic flux was 
analyzed by measuring the extracellular pH, glucose, lacate and pyruvate levels. 
15 
In order to confirm the role of PKA in these processes, for Specific Aim 4, I 
determined whether restoration of PKA activity in 123.7 cells abrogated 
differences in hypoxic susceptibility and energy homeostasis between the two 
cell lines. The PKA-activity deficient 123.7 cells were transfected with an active 
catalytic a subunit of Protein Kinase A. Transfection efficiency was verified 
through PKA activity assays and western blotting of the PKA cat a subunit. 
Using the transfected cells, hypoxia-induced cell survival, oxidative stress, 
energy status, glycolytic flux, and mitochondrial function were examined to 
confirm the role of PKA in these processes. 
Through these experiments, I hoped to determine the role of Protein 
Kinase A in hypoxia-induced cell death. Clarification of the cellular response to 
low oxygen conditions is essential to the treatment of pathologies characterized 
by periods of hypoxia. Understanding the role of PKA in the regulation of cellular 
metabolic responses, oxidative stress, and cell survival to hypoxia may provide 
novel therapeutic opportunities to improve cellular adaptation and recovery. 
16 
Specific Aim 1: To determine whether PKA activity affects cellular tolerance to 
hypoxia and production of oxidant species 
1 (A) To iderdify PKA-medlated changes In hypoxic vulnerability 
WTcells 
123.7 cells 
RA, SH 0.1% 02 
MlT I Trypan Blue 
Cell survival 
1 (8) To determine the role of PKA in hypoxl.induced oxidant stress 
WTcells 
123.7 cells 
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mechanisms that will affect hypoxia-induced oxidative stress 
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Specific Aim 2: To determine whether PKA regulates hypoxia-induced cell 
death via oxidative stress and/or energy depletion 





I Cellular energy status 
2 (8) To determine whether ROS contribute to hypoxia-induced energy failure 
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.. Cellular energy status 
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Specific Aim 3: To determine whether PKA affects cellular energetic status 
through regulation of metabolic pathways 
3 (A) To determine whether PKA plays a role in the regulation of mitochondrial function 
WTcells 
123.7 cells 
RA, SH 0.1% O2 ~ Mitochondrial potential 
~ Mitochondrial protein 
Correlates with mitochonmial aboodance 
3 (B) To determine the effect of PKA activity on glycolytic flux 
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Specific Aim 4: To determine whether restoration of PKA activity in 123 .7 
cells will abrogate differences in hypoxic susceptibility and energy 
homeostasis between the two cell types 
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MATERIALS AND METHODS 
Cell Culture and Hypoxic Exposures: WT and PKA-deficient (123.7) PC-12 cells 
were kindly provided by Dr. JA Wagner from Cornell University and grown on 
collagen coated plates in RPMI1640 medium (Gibco/lnvitrogen, Carlsbad, CA), 
supplemented with 10% horse serum and 5% fetal bovine serum. Cells were 
exposed to hypoxia (0.1 % or 5% O2, 5% CO2, balanced N2)' using a custom-
designed, computer controlled incubator chamber attached to an external 02/C02 
computer-driven controller (Biospherix, Redfield, NY) as previously described 
(48,49). 
Cell viability: Cell viability was measured as previously described (45,49,50) by 
assessment of 3-(4,5-dimethyldiazol-2yl)-2,5,-diphenyltetrazolium bromide (MIT) 
reduction (Sigma Chemical, St. Louis, MO). MIT was added to the cell cultures 
one hour prior to the end of the hypoxic exposure and incubated at 37°C. Cells 
were collected by centrifugation and resuspended in DMSO for 24h. Absorption 
of reduced MIT was measured at 340 nm using a Multiskan EX plate reader 
(Thermo electron corporation, Milford, MA) and values for DMSO blanks were 
subtracted. Cell survival was also analyzed using Trypan Blue (J.T. Baker, 
Philipsburg, NJ) exclusion as a marker of live cells with intact membranes. Cells 
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were collected, resuspended in PBS/trypan, counted using a hematocytometer, 
and total cell number was calculated and averaged. 
cAMP determination: Intracellular cAMP levels were determined using a 
chemiluminescent immunoassay kit according to the manufacturer's instructions 
(Upstate, Temecula, CA). In this kit, a 96-well plate was precoated with a 
capture antibody. Standards and samples were mixed with an anti-cAMP 
antibody, as well as an alkaline phosphatase-labeled cAMP conjugate. The 
conjugate competes with native cAMP in the standards and samples for binding 
sites on the antibody. Thus, chemiluminescence levels are inversely related to 
the amount of cAMP in the standards and samples. Luminescence was detected 
using a SpectraFluor Plus (Tecan, San Jose, CA). 
A TP determination: Intracellular ATP levels were determined using a 
bioluminescence A TP determination kit according to the manufacturer's 
instructions (Alexis Biochemicals, San Diego, CA). In this kit, the enzyme 
luciferase uses endogenous cellular ATP to catalyze the formation of light from 
luciferin. Luminescence was detected using a Spectra Fluor Plus (Tecan, San 
Jose, CA). 
Reactive oxygen species: Formation of intracellular oxidant speCies was detected 
by fluorescence, using the cell permeable, non-fluorescent 2'-7' 
dichlorodihydrofluorescin diacetate (DCFH2-DA; Molecular Probes, Eugene, OR), 
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which is de-esterified in cells by endogenous esterases and trapped. 2'-7' 
dichlorofluorescin is oxidized by intracellular oxidant species to fluorescent 2'-7' 
dichlorofluorescein. Cells were loaded for 1 h with 5 ~M DCFH2-DA, washed, and 
fluorescence was measured at 485 nm excitation and 535 nm emission using a 
SpectraFluor Plus (Tecan, San Jose, CA) For antioxidant treatments, cells were 
pretreated with 2.5 mM N-acetyl cysteine (Sigma, S1. Louis, MO) for 1 hour prior 
to hypoxic exposure. 
Extracellular Glucose determination: Growth media was analyzed for glucose 
levels using the Amplex Red Glucose/Glucose Oxidase Assay Kit (Molecular 
Probes, Eugene, OR). In this assay, D-glucose present in the growth media 
reacts with glucose oxidase to from D-gluconolactone and hydrogen peroxide 
(H202). The Amplex Red reagent (10-acetyl-3,7-<iihydroxyphenoxazine) reacts 
with H202 in the presence of horseradish peroxidase to generate the fluorescent 
product, resorufin. Fluorescence was measured in a 96-well plate at 550 nm 
excitation and 595 nm emission using a SpectraFluor Plus (Tecan, San Jose, 
CA) 
Extracellular Lactate determination: Growth media samples without phenol red 
were collected from cell cultures, deproteinized with perchloric acid, and 
centrifuged at 8,000 rpm for 5 min at 4°C. Samples were neutralized using a 
KOH/Na2HP04 solution and added in duplicate to a 96-well plate, with lactate 
standards and controls. The assay reactant (O.2M Glycine-semicarbazide, 0.003 
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M NAD, and 14 U/ml lDH) was added to the samples and incubated for 1h at 
37°C. Optical density was read at 340 nm and subtracted from background 
using a SpectraFluor Plus (Tecan, San Jose, CA). All chemicals were analytical 
grade (Sigma Chemical, St. louis, MO). 
Extracellular Pyruvate determination: Growth media samples without phenol red 
were collected from cell cultures, deproteinized with perchloric acid, and 
centrifuged at 8,000 rpm for 5 min at 4°C. Samples were neutralized using a 
KOH/Na2HP04 solution and added in duplicate to a 96-well plate, with pyruvate 
standards and controls. The assay reactant (0.083 M Tris-HCl, 0.0083 M EDTA, 
0.75 mM NADH, 15 U/ml lDH) was added to the samples and incubated for 15 
min at room temperature. Optical density was read at 340 nm and subtracted 
from background using a SpectraFluor Plus (Tecan, San Jose, CAl. All 
chemicals were analytical grade (Sigma Chemical, St. louis, MO). 
Preparation of Cell Lysates and Western Blotting: Cells were collected by 
centrifugation and pellets were resuspended in RIPA buffer (PBS, 1% NP-40, 
0.5% Deoxycholate, 1% SDS, 1 mM Sodium orthovanadate, 0.5 mM PMSF, 10 
mg/ml Aprotinin, 20 mg/ml leupeptin), incubated on ice for 30 min., briefly 
sonicated, and centrifuged at 4°C at 15,000 rpm for 10 min. Total protein 
concentration in the supernatant was determined using a DC-Bio-Rad protein 
assay (Bio-Rad, Hercules, CAl. Immunoblotting was done as described 
previously (5,47,49,51 ,52). Samples were diluted in buffer (125 mM Tris, 5% 
24 
Glycerol, 4% Sodium dodecyl sulfate, 0.1 M Dithiothreitol, 0.0025% Pyronin Y-
pink, ddH20) and loaded onto 4-12% Tris-Glycine gels (Invitrogen, Carlsbad, CA). 
Gels were run in buffer (25 mM Tris, 193 mM Glycine, 0.1 % Sodium dodecyl 
sulfate, ddH20) for 2h at 120 V, and transferred onto nitrocellulose filter 
membranes for 1h at 30V in transfer buffer (12 mM Tris, 96 mM Glycine, 20% 
Methanol). Membranes were stained with Ponceau-S to ensure proper transfer, 
and blocked (5% non-fat dry milk in Tris buffered saline and 0.05% Tween-20) for 
1 hour. Membranes were incubated with primary antibodies overnight at 4°C, 
washed, and incubated with secondary antibodies for 1 h at room temperature. 
Membranes were then washed, and chemiluminescence was detected using an 
ECl plus western blotting detection kit (GE Healthcare, Buckinghamshire, UK). 
Membranes were immunoblotted for j3-actin to ensure loading efficiency. 
Mitochondrial Membrane Potential Assay (MMP): MMP was determined with the 
fluorescent probe 5,5' ,6,6' -tetrachloro-1 ,1' ,3,3' -tetraethylbenzimidazolyl 
carbocyanine iodide (JC-1). JC-1 undergoes a reversible change in fluorescence 
emission from green to red upon an increase in mitochondrial potential. Thus, in 
live cells, JC-1 acccumulates as red aggregates in the mitochondria, while in 
apoptotic or necrotic cells it remains in the green monomeric form. The 
fluorescence ratio was detected in a 96-well plate according to the 
manufacturer's instructions (Cell Technology, Mountain View, CA). Red 
fluorescence was measured at 550 nm excitation and 595 nm emission, and 
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green fluorescence was measured at 485 nm excitation and 535 nm emission 
using a SpectraFluor Plus (Tecan, San Jose, CA). 
Glutathione (GSHIGSSG) ratio and Total Glutathione: The glutathione ratio and 
total glutathione levels were determined using a fluorescent kit according to the 
manufacturer's instructions (Biovision, Mountain View, CA). In this kit 0-
phthalaldehyde reacts with the reduced form of glutathione (GSH), but not the 
oxidized form (GSSG), to form a fluorescent product. GSH, GSSG, and total 
glutathione levels were detected in separate wells in a 96-well plate. In order to 
detect GSSG, a GSH quencher was added to rid the samples of endogenous 
GSH. GSSG in the samples was then converted to GSH using a reducing agent, 
and fluorescence was detected. To detect total glutathione, the reducing agent 
was added to convert endogenous GSSG to GSH, and fluorescence was 
measured using a SpectraFluor Plus (Tecan, San Jose, CA). 
Cell Transfection: Tranfections were done using the FuGENE HD transfection 
reagent (Roche Applied Science, Indianapolis, IN). Plasmids encoding active 
PKA-cat a were kindly provided by Dr. G. Stanley McKnight, and used as 
previously described (53). pcDNA 3.0 (Invitrogen, Carlsbad, CA) was used as a 
vector control with FuGene reagent. 
PKA Activity Assay: PKA activity was analyzed as previously described (54). 
Cells were collected and lysed as described above, and total protein 
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concentration in the supernatant was determined using a DC-Bio-Rad protein 
assay (Bio-Rad, Hercules, CA). Duplicate samples (50 Ilg protein) were diluted 
in Kinase Buffer (25 mM Hepes, pH 7.4; 20 mM MgCI2; 20 mM~­
glycerophosphate; 0.1 mM Sodium orthovanadate; 2 mM DTT, 1 mL dd H20), in 
the presence or absence of a PKA inhibitory peptide, PKI 6-22 amide (26.7 IlM, 
Calbiochem, La Jolla, CA) to account for PKA-independent phosphorylation. 
Reaction Buffer (200 IlM Kemptide; 55.6 nM 32P-ATP; Kinase Buffer) was added 
and samples were incubated for 30 min at 30°C in a water bath. Aliquots of each 
sample were removed from the tube and spotted on Whatman filter paper p81 
(Whatman International Ltd, Maidstone, England). Filter papers were washed for 
5 minutes with 1 % phosphoric acid and the waste was drained. Washes were 
repeated for 15 min with 1% phosphoric acid, and 15 minutes with ddH20 to 
remove non-specifically bound radioactivity. Radioactivity, representative of 32P 
incorporation into the substrate, was counted using a Packard Tri-carb Liquid 
Scintillation Analyzer 2100TR (Perkin Elmer Life & Analytical Sciences, Shelton, 
CT). 
Statistical Analyses: Statistical analyses were performed using SigmaStat 
software version 3.5.1 (Systat Software, Inc., San Jose, CA). Data represented 
as the means of individual experiments, with the error bars indicating standard 
deviations. Statistical tests were performed as indicated in the results, with 
significance defined as p<.05. 
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RESULTS: 
Specific Aim 1: To determine whether PKA activity affects cellular tolerance to 
hypoxia and production of oxidant species 
1 (A) Effect of PKA activity on cell survival to hypoxia: MTT assays indicated that 
severe hypoxia induced cell death by 24h in WT cells, while a milder hypoxic 
challenge did not significantly affect cell survival (Figure 10). In contrast, 123.7 
cells did not exhibit cell death following 24h of severe hypoxic exposure (Figure 
11). In addition, basal MTT values were also lower in 123.7 cells, compared to 
WT cells at a similar confluence, as verified by Trypan Blue exclusion assays 
(Figure 12). This indicates that PKA activity contributes to PC-12 hypoxic cell 
death. The consistent difference in cellular reductive capacity, as indicated by 
the MTT assays, implicates PKA signaling in the regulation of cellular metabolism 
and suggests that the metabolic function of the two cell lines may differ. 
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Figure 10. Cellular Tolerance of WT cells to Sustained Hypoxia: MTT Assay 
WT cells were exposed to room air (RA), severe hypoxia (SH 0.1 % oxygen), or a 
milder hypoxia (SH 5% oxygen). Cell viability was analyzed using the reduction 
of MTT (3-(4,5-dimethyldiazol-2yl)-2,5,-diphenyltetrazolium bromide). WT cell 
death occurred following 24h of severe (0.1 % 02) hypoxia, but was not seen at 
any other time point of severe hypoxia, or with milder hypoxic exposure. Data 
expressed as the means of 5 individual experiments (n=5), with error bars 
indicating standard deviations. One-way ANOVA, Mann Whitney Rank Sum test. 
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Figure 11. Cellular Tolerance of 123.7 cells to Sustained Hypoxia: MTT 
Assay PKA-activity deficient 123.7 cells were exposed to room air (RA), severe 
hypoxia (SH 0.1 % oxygen), or a milder hypoxia (SH 5% oxygen). Cell viability 
was analyzed using the reduction of MTT (3-(4,5-dimethyldiazol-2yl)-2,5,-
diphenyltetrazolium bromide). MTT reduction in 123.7 cells was significantly 
increased from RA controls at later time pOints of hypoxic exposure, indicating 
that 123.7 cells are not experiencing cell death over this time course. Data 
expressed as the means of 5 individual experiments (n=5), with error bars 
indicating standard deviations. One-way ANOVA, Tukey post-hoc test, * p<.01 
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WTRA24h WT SH 0.1% 24h 123.7 RA24h 123.7 SH 0.1% 24h 
Figure 12. Trypan Blue Exclusion Assay WT and 123.7 cells were exposed 
to either room air (RA) or sustained 0.1 % 02 hypoxia (SH 0.1 %) for 24h. Cell 
viability was assessed using the Trypan Blue exclusion assay. The number of 
live cells per well was significantly decreased in WT cells following 24h of severe 
hypoxia, while 123.7 cells had no change in the number of live cells. Data 
expressed as means of 10 individual experiments (n=10), with error bars 
indicating standard deviations. Two-way ANOVA, Tukey post-hOC test, *p<.001 
RA vs. SH 0.1 % 02 for one cell line. 
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1 (8) Effect of PKA activity on Oxidative Stress: DCF fluorescence, indicating 
reactive oxygen species production, significantly increased in WT cells exposed 
to 24h severe hypoxia (0.1% 02) (Figure 13). In contrast to WT cells, the PKA-
activity deficient 123.7 cells had no significant alterations in DCF fluorescence 
following exposure to 0.1 % O2 for 24h, (Figure 13), suggesting that PKA activity 
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WTRA24h WT SH 0.1% 24h 123.7 RA 24h 123.7 SH 0.1% 24h 
Figure 13. Reactive Oxygen Species Production: DCF Fluorescence WT and 
123.7 cells were exposed to either room air (RA) or sustained 0.1 % 02 hypoxia 
(SH 0.1 %) for 24h. ROS levels, as detected by dichlorofluorescein (DCF) 
fluorescence, were significantly increased in WT cells following 24h of severe 
hypoxia, while 123.7 cells experienced no significant alterations in DCF 
fluorescence. Data expressed as the means of the relative fluorescence units 
(RFU) from 14-16 individual experiments (n=14-16), with error bars indicating 
standard deviations. Two-way ANOVA, Tukey Post-hoc test, *p<.001 RA vs. SH 
0.1 % 02 for one cell line. 
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1 (C) Effect of PKA on cellular antioxidant response: Following 24h of severe 
hypoxia, there was surprisingly no detectable difference in the GSH/GSSG ratio 
(Figure 14) or total glutathione levels in either WT or 123.7 cells (Figure 15). 
However, it is important to note that most of the detected glutathione was in the 
oxidized (GGSG) state during both normoxic and hypoxic states. This indicates 
that, in our PC-12 cell lines, the reductive capacity of the glutathione system may 
already be compromised, even during normoxic conditions. Furthermore, 
superoxide dismutase 1 (SOD-1) expression was not altered in either cell line 
with 24h of sustained hypoxia or with antioxidant treatment (Figure 16), indicating 













WTRA24h WT SH 0.1% 24h 123.7 RA 24h 123.7 SH 0.1% 24h 
Figure 14. Cellular Redox Status: GSH/GSSG ratio WT and 123.7 cells were 
exposed to either room air (RA) or sustained 0.1 % 02 hypoxia (SH 0.1 %) for 24h. 
The ratios of reduced to oxidized forms of glutathione were analyzed as an 
indicator of cellular antioxidant response. Data expressed as the means of the 
relative fluorescence units (RFU) from 5 individual experiments (n=5), with error 
bars indicating standard deviations. Two-way ANOVA statistics did not detect a 
significant difference between the GSH/GSSG ratios of the two cell types, or 













WTRA24h WT SH 0.1% 24h 123.7 RA 24h 123.7 SH 0.1% 24h 
Figure 15. Cellular Redox Status: Total Glutathione The total levels of 
glutathione were assessed in WT and 123.7 cells exposed to either room air (RA) 
of sustained 0.1 % 02 hypoxia (SH 0.1 %) for 24h. Data expressed as means of 
the relative fluorescence units (RFU) of 5 individual experiments (n=5), with error 
bars indicating standard deviations. Two~way ANOVA statistics did not detect a 
significant difference between the total glutathione levels of the two cell types, or 




















Figure 16. Cellular Antioxidant Capacity: 500-1 Expression WT and 123.7 
cells were exposed to either room air (RA) or sustained 0.1 % 02 hypoxia (8H 
0.1 %) for 24h. Groups were also pre-treated for 1 h with the antioxidant 
precursor N-acetyl cysteine (NAC). Western blotting of superoxide dismutase-1 
(800-1 ) was performed to analyze the cellular antioxidant responses, and 
loading efficiency was confirmed through immunoblotting of f3-actin. No 
alterations in 800-1 or f3-actin expression were seen between the WT and 123.7 
cells, or in either cell line upon hypoxic exposure or with antioxidant pre-
treatment. Data representative of 3 individual experiments. 
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Specific Aim 2: To determine whether PKA regulates hypoxia-induced cell death 
via oxidative stress and/or energy depletion 
2 (A) Effect of PKA Activity on Cellular Energetic Status: Severe hypoxia 
decreased ATP levels in WT cells by 24h, while 123.7 cells displayed no change 
in ATP levels (Figure 17). Furthermore, 123.7 cells had a lower basal level of 
ATP, indicating that PKA activity may playa role in determining cellular energy 
requirements. The hypoxia-induced decrease in ATP coincided with the onset of 
cell death in WT cells, however lower baseline ATP levels did not appear to be 
detrimental to 123.7 cell survival. 
In 123.7 cells, the mutated PKA regulatory subunit prevented the binding 
of cAMP, and thus, could potentially affect cAMP synthesis or degradation and 
alter cAMP levels within the cells. However, there was no alteration of cAMP 
levels between the WT and 123.7 cells, or upon exposure to 24h of severe 

















WT SH 0.1% 24h 123.7 RA24h 123.7 SH 0.1% 24h 
Figure 17. Cellular Energetic Status: AlP levels WT and PKA activity-
deficient 123.7 cells were exposed to either room air (RA) or sustained 0.1% O2 
hypoxia (SH 0.1%) for 24h. ATP levels were significantly decreased in WT cells 
following 24h of hypoxic exposure, while 123.7 cells displayed no change in ATP 
levels. The 123.7 cells also had a lower basal level of ATP than WT cells. Data 
expressed as the means of relative luminescence units (RLU) from 7 individual 
experiments (n=7), with error bars indicating standard deviations. Two-way 
AN OVA, Tukey Post-hoc test, ** p<.005 as indicated, * p<.01 RA vs. SH 0.1% 
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Figure 18. Cellular Energetic Status: cAMP levels WT and 123.7 cells were 
exposed to either room air (RA) or sustained 0.1 % 02 hypoxia (SH 0.1 %) for 24h, 
and their cAMP levels were analyzed. Two-way ANOVA statistics did not detect 
a significant difference between the cAMP levels of the two cell types, or 
between room air and hypoxia treated groups in each cell type. Data expressed 
as the means of 5-6 individual experiments (n=5-6), with error bars indicating 
standard deviations. 
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2 (8) Effect of ROS on Hypoxia-induced Energy Failure Pre-treatment of WT 
cells with the antioxidant N-acetyl cysteine, 1 h prior to 24h SH 0.1 % 02, reduced 
ROS levels as detected by DCF fluorescence (Figure 19). Antioxidant treatment 
also improved cell survival assessed by Trypan blue exclusion (Figure 20), 
indicating that oxidative stress contributes to hypoxia-induced PC-12 cell death. 
N-acetyl cysteine treatment led to a drastic shift in the reduction state of 
the cell, as shown by the large increase in the GSH/GSSG ratio in both normoxic 
and hypoxic conditions (Figure 21). However, N-acetyl cysteine treatment did 
not affect the total glutathione levels in the cell (Figure 22), indicating that the 
antioxidant may be directly acting as a reducing agent for the existing pool of 
oxidized GSSG rather than increasing generation of new glutathione. 
Furthermore, pretreatment with the antioxidant N-acetyl cysteine, while 
rescuing WT cells from cell death, had no effect on ATP levels (Figure 23), 
suggesting that oxidative stress may not be sufficient to induce cellular energy 
depletion during hypoxia. This data suggests that while hypoxic stress depletes 
ATP levels, energy depletion does not appear to be directly causing death. 
cAMP levels were not Significantly affected by treatment with the antioxidant N-
acetyl cysteine in either of the cell types (Figure 24), suggesting that cAMP levels 
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+ NAC 24h - 24h + NAC 24h - 24h + NAC 0.1 % 24h - 24h + NAC 
Figure 19. Effect of Antioxidant treatment on DCF Fluorescence WT and 
123.7 cells were exposed to either room air (RA) or sustained 0.1 % O2 hypoxia 
(SH 0.1 %) for 24h. Dichlorofluorescein (DCF) fluorescence, indicative of ROS 
levels, was analyzed in cells pre-treated with the antioxidant N-acetyl cysteine 
relative to untreated controls. N-acetyl cysteine treated groups had lower values 
of DCF fluorescence than the untreated controls. Data expressed as the means 
of relative fluorescence units (RFU) from 5-6 individual experiments (n=5-6), with 
error bars indicating standard deviations. Two-way ANOVA, Tukey Post-hoc test, 
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Figure 20. Effect of Antioxidant treatment on Trypan Blue Exclusion Assay 
WT and 123.7 cells were exposed to either room air (RA) or sustained 0.1 % 02 
hypoxia (SH 0.1 %) for 24h. Trypan Blue exclusion assays were analyzed in cells 
pre-treated with the antioxidant N-acetyl cysteine relative to untreated controls to 
analyze cell viability. WT cells exposed to hypoxia had a significant increase in 
the number of live cells when pre-treated with N-acetyl cysteine, while the 
antioxidant treatment did not have a significant effect on the other groups tested. 
Data expressed as the means of 5 individual experiments (n=5), with error bars 
indicating standard deviations. Two-way ANOVA, Tukey Post-hoc test, * p=.01 
N-acetyl cysteine pre-treated cells vs. non-treated cells of the same oxygen 
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Figure 21. Effect of Antioxidant treatment on GSH/GSSG ratio WT and 
123.7 cells were exposed to either room air (RA) or sustained 0.1 % 02 hypoxia 
(SH 0.1 %) for 24h. The ratio of reduced to oxidized glutathione (GSH/GSSG), 
indicative of cellular antioxidant status, was analyzed in cells pre-treated with the 
antioxidant N-acetyl cysteine relative to untreated controls. Pre-treatment with 
the antioxidant significantly increased the ratio of reduced to oxidized glutathione 
in all of the groups tested. Data expressed as the means of relative fluorescence 
units (RFU) from 5 individual experiments (n=5), with error bars indicating 
standard deviations. Two-way ANOVA, Tukey post hoc t-test, p<.001 N-acetyl 
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24h NAC 0.1% 24h NAC 24h + NAC 0.1% 24h + NAC 
Figure 22. Effect of Antioxidant Treatment on Total Glutathione Levels WT 
and 123.7 cells were exposed to either room air (RA) or sustained 0.1 % 02 
hypoxia (SH 0.1 %) for 24h. Total glutathione levels were analyzed in cells pre-
treated with the antioxidant N-acetyl cysteine relative to untreated controls. 
Antioxidant treatment did not have an effect on any of the tested groups. Data 
expressed as the means of relative fluorescence units (RFU) from 5 individual 
experiments (n=5), with error bars indicating standard deviations. One-way 
ANOVA statistics did not detect a significant difference between the total 
glutathione levels of N-acetyl cysteine pre-treated cells vs. non-treated cells in 








WTRA24h WTRA24h WTSHO.1% WTSHO.1% 123.7RA 123.7RA 123.7SH 123.7SH 
+ NAC 24h 24h + NAC 24h 24h + NAC 0.1% 24h 0.1% 24h + 
NAC 
Figure 23. Effect of Antioxidant treatment on ATP levels WT and 123.7 cells 
were exposed to either room air (RA) or sustained 0.1 % O2 hypoxia (SH 0.1 %) 
for 24h. ATP levels were analyzed in cells pre-treated with the antioxidant N-
acetyl cysteine relative to untreated controls. Antioxidant treatment had no effect 
on ATP levels in any of the tested groups. Data expressed as the means of 
relative luminescence units (RLU) from 4 individual experiments (n=4), with error 
bars indicating standard deviations. One-way ANOVA statistics did not detect a 
significant difference between the ATP levels of N-acetyl cysteine pre-treated 
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NAC 24h NAC 24h NAC 0.1% 24h NAC 
Figure 24. Effect of Antioxidant treatment on cAMP levels WT and 123.7 
cells were exposed to either room air (RA) or sustained 0.1 % O2 hypoxia (SH 
0.1%) for 24h. cAMP levels were analyzed in cells pre-treated with the 
antioxidant N-acetyl cysteine relative to untreated controls. Antioxidant treatment 
had no effect on the levels of cAMP in any of the tested groups. Data expressed 
as the means of 5-6 individual experiments (n=5-6), with error bars indicating 
standard deviations. One-way ANOVA statistics did not detect a significant 
difference between the cAMP levels of N-acetyl cysteine pre-treated cells vs. 
non-treated cells in WT or 123.7 cells 
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Specific Aim 3: To determine whether PKA affects cellular energetic status 
through regulation of metabolic pathways 
3 (A) Effect of PKA on mitochondrial potential and abundance: WT and PKA 
activity-deficient 123.7 cells had a small, insignificant decrease in JC-1 ratio upon 
hypoxic exposure (Figure 25). However, 123.7 cells exhibited higher JC-1 
red/green ratios than WT cells overall (Figure 25). While treatment with the 
antioxidant N-acetyl cysteine rescued WT cells from hypoxic cell death, it did not 
restore RA JC-1 ratios (Figure 25), suggesting that mitochondrial potential is not 
the primary cause of cell death at 24h hypoxia. These data suggests that 
mitochondrial potential may be compromised at the onset of cellular death, and 
that PKA may have an inhibitory effect on mitochondrial metabolism. 
COX IV expression decreased after 24h SH in both cell lines (Figure 26). 
However, 123.7 cells displayed significantly higher expression of COX IV than 
WT cells during RA and SH 0.1 % 24h (Figure 26), suggesting an increase in 
mitochondrial enzyme or a mitochondrial enrichment when PKA was inactivated. 
Pretreatment with NAC did not prevent the SH-induced decrease in COX IV 
expression (Figure 26), suggesting again that increases in ROS may occur 
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Figure 25. Mitochondrial Potential: JC-1 Assay WT and 123.7 cells were 
exposed to either room air (RA) or sustained 0.1 % 02 hypoxia (SH 0.1 %) for 24h. 
Fluorescence of 5,5' ,6,6' -tetrachloro-1 , l' ,3,3' -tetraethylbenzimidazolyl 
carbocyanine iodide (JC-1) was analyzed as an indicator of mitochondrial 
potential. Cells were pre-treated with the antioxidant N-acetyl cysteine and 
compared to untreated controls. Exposure to hypoxia resulted in a small, 
insignificant decrease in JC-1 fluorescence, but antioxidant treatment had no 
effect on JC-1 fluorescence ratios. The 123.7 cells, however, had higher overall 
JC-1 levels than WT cells. Data expressed as the means of relative fluorescence 
units (RFU) from 5 individual experiments (n=S), with error bars indicating 
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Figure 26. Effect of Antioxidant Treatment on COX IV Expression WT and 
123.7 cells were exposed to either room air (RA) or sustained 0.1 % 02 hypoxia 
(SH 0.1 %) for 24h. Cells were pre-treated with the antioxidant N-acetyl cysteine 
(NAC) and compared to untreated controls. The expression of cytochrome 
oxidase IV (COX IV) was analyzed and loading efficiency was confirmed through 
immunoblotting of p-actin. Both WT and 123.7 cells had a decrease in COX IV 
expression after 24h of hypoxic exposure. However, 123.7 cells displayed higher 
COX IV expression than WT cells at both room air and sustained hypoxia. N-
acetyl cysteine treatment had no effect on COX IV protein levels. Results 
representative of 3 individual experiments (n=3). 
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3 (8) Effect of PKA activity on glycolytic flux: Media glucose levels were lower in 
normoxic WT cells 24h after plating the cells, compared to 123.7 cells (Figure 
27), indicating that WT cells have higher rate of glucose consumption and may 
have higher metabolic requirements for their basal metabolism. Hypoxia 
enhanced these differences between the cell types, with an increased uptake of 
glucose in 123.7 cells, but complete depletion of extracellular glucose in WT 
cells. 
Extracellular pH decreased in both cell types upon hypoxic exposure 
(Figure 28), but WT cells displayed lower pH values under normoxic and hypoxic 
conditions. Hypoxia increased lactate production in both cell types (Figure 29), as 
expected from their increased glucose utilization, suggesting upregulation of 
anaerobic metabolism. However, WT cells displayed higher lactate values at 
normoxic and hypoxic states, indicating that PKA signaling may enhance 
glycolytic flux. 
In addition, WT cells exhibited higher extracellular pyruvate levels under 
normoxic conditions (Figure 30), but were unaffected by hypoxic exposure. The 
PKA activity-deficient 123.7 cells displayed an increase in extracellular pyruvate 
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Media WTRA24h WT SH 0.1% 24h 123.7 RA 24h 123.7 SH 0.1% 24h 
Figure 27. Glyolytic Flux: Extracellular Glucose WT and 123.7 cells were 
exposed to either room air (RA) or sustained 0.1 % 02 hypoxia (SH 0.1 %) for 24h. 
Extracellular glucose levels were significantly lower in WT cells than in 123.7 
cells following 24h of RA exposure. Hypoxic exposure enhanced these 
differences, with depletion of extracellular glucose stores in the WT cell line. 
Data expressed as the means of 8-10 individual experiments (n=8-10), with error 
bars indicating standard deviations. Two-way ANOVA, Tukey Post-hoc test, * 


















WTRA24h WT SH 0.1% 24h 123.7 RA 24h 123.7 SH 0.1% 24h 
Figure 28: Glycolytic Flux: Extracellular pH WT and 123.7 cells were 
exposed to either room air (RA) or sustained 0.1 % O2 hypoxia (SH 0.1 %) for 24h. 
Both WT and 123.7 cells had a drop in extracellular pH following 24h of hypoxic 
exposure. However, extracellular pH was higher in 123.7 cells than in WT cells 
in both normoxic and hypoxic conditions. Data expressed as the means of 10 
individual experiments (n=10), with error bars indicating standard deviations. 






















WTRA24h WT SH 0.1% 24h 123.7 RA 24h 123.7 SH 0.1% 24h 
Figure 29. Glycolytic Flux: Extracellular Lactate WT and 123.7 cells were 
exposed to either room air (RA) or sustained 0.1% O2 hypoxia (SH 0.1%) for 24h. 
Extracellular lactate was increased in both WT and 123.7 cells following hypoxic 
exposure. However, WT cells had higher extracellular lactate levels than 123.7 
cells in both normoxic and hypoxic conditions. Data expressed as the means of 
10 individual experiments (n=10), with error bars indicating standard deviations. 
Two-way ANOVA, Tukey Post-hoc test, * p s .001 as indicated or RA 24h vs. SH 
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WTRA24h WT SH 0.1% 24h 123.7 RA 24h 123.7 SH 0.1% 24h 
Figure 30. Glycolytic Flux: Extracellular Pyruvate WT and 123.7 cells were 
exposed to either room air (RA) or sustained 0.1% O2 hypoxia (SH 0.1%) for 24h. 
WT cells had a higher level of extracellular pyruvate than 123.7 cells under 
normoxic conditions, but experienced no change in extracellular pyruvate after 
24h of sustained hypoxia. The 123.7 cells, however, had significantly higher 
levels of extracellular pyruvate following hypoxic exposure. Data expressed as 
the means of 10 individual experiments (n=10), with error bars indicating 
standard deviations. Two-way ANOVA, Tukey Post-hoc text, ** p<.001 as 
indicated, * p<.01 RA 24h vs. SH 0.1 % 24h in each cell type. 
55 
3 (C) Effect of Hypoxia-Induced Oxidant Stress on Glycolytic Flux: Extracellular 
glucose levels were unaffected by antioxidant treatment with N-acetyl cysteine 
(Figure 31). suggesting that PKA activity may contribute to the upregulation of 
glucose use under hypoxic states independently from oxidative stress. Hypoxia-
induced decreases in pH were also unaffected by NAC treatment (Figure 32). 
Furthermore, treatment with N-acetyl cysteine did not affect lactate or pyruvate 
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Figure 31. Effect of Antioxidant treatment on Extracellular Glucose WT and 
123.7 cells were exposed to either room air (RA) or sustained 0.1 % 02 hypoxia 
(SH 0.1 %) for 24h. Cells were pre-treated with the antioxidant N-acetyl cysteine 
and compared to untreated controls. One-way ANOVA statistics did not detect a 
significant difference between the extracellular glucose levels of N-acetyl 
cysteine pre-treated cells vs. non-treated cells in WT or 123.7 cells. Data 
expressed as the means of 6-9 individual experiments (n=6-9), with error bars 
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24h - NAG 0.1% 24h- NAG 24h - + NAG 0.1% 24h- + NAG 
Figure 32. Effect of Antioxidant treatment on Extracellular pH WT and 123.7 
cells were exposed to either room air (RA) or sustained 0.1 % O2 hypoxia (SH 
0.1 %) for 24h. Cells were pre-treated with the antioxidant N-acetyl cysteine and 
compared to untreated controls. One-way ANOVA statistics did not detect a 
significant difference between the extracellular pH levels of N-acetyl cysteine pre-
treated cells vs. non-treated cells in WT or 123.7 cells. Data expressed as the 
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Figure 33. Effect of Antioxidant Treatment on Extracellular Lactate WT and 
123.7 cells were exposed to either room air (RA) or sustained 0.1 % O2 hypoxia 
(SH 0.1%) for 24h. Cells were pre-treated with the antioxidant N-acetyl cysteine 
and compared to untreated controls. One-way ANOVA statistics did not detect a 
significant difference between the extracellular lactate levels of N-acetyl cysteine 
pre-treated cells vs. non-treated cells in WT or 123.7 cells. Data expressed as 

















WTRA WTRA+ WTSH WTSH 123.7 RA 123.7 RA 123.7 SH 123.7 SH 
24h - HAC 0.1% 24h 0.1% + 24h - + HAC 0.1% 24h 0.1% + 
HAC HAC 
Figure 34. Effect of Antioxidant Treatment on Extracellular Pyruvate WT 
and 123.7 cells were exposed to either room air (RA) or sustained 0.1 % 02 
hypoxia (SH 0.1 %) for 24h. Cells were pre-treated with the antioxidant N-acetyl 
cysteine and compared to untreated controls. One-way ANOVA statistics did not 
detect a significant difference between the extracellular pyruvate levels of N-
acetyl cysteine pre-treated cells vs. non-treated cells in WT or 123.7 cells. Data 
expressed as the means of 10 individual experiments (n=10), with error bars 
indicating standard deviations. 
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Specific Aim 4: To determine whether restoration of PKA activity in 123.7 cells 
will abrogate differences in hypoxic susceptibility and energy homeostasis 
between the two cell types. 
Transfection of 123.7 cells with active PKA catalytic a subunit: 123.7 cells were 
transfected with plasm ids encoding active PKA catalytic ex subunit to restore PKA 
activity in these cells. Over-expression of PKA cat ex was verified by Western 
blotting and PKA activity assays. Western blotting displayed an increase in PKA 
cat ex expression in transfected cells at both RA and SH (Figure 35). Increased 
PKA enzymatic activity in transfected 123.7 cells after 24h SH was detected by 















Figure 35. Effect of PKA cat a Transfection on PKA cat a expression PKA 
activity-deficient 123.7 cells were transfected with empty vectors or plasmids 
encoding the active catalytic subunit of Protein Kinase A (PKA cat-a.). Following 
transfection, cells were exposed to either room air (RA) or sustained 0.1 % O2 
hypoxia (SH 0.1%) for 24h. The expression of PKA cat-a. was analyzed and 
loading efficiency was verified through immunoblotting of l3-actin. The mutant 
123.7 cells transfected with the active catalytic subunit of PKA had increased 
expression of PKA cat-a. under room air and sustained hypoxia conditions. 
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Figure 36. Effect of PKA cat a Transfection on PKA Activity levels PKA 
activity-deficient 123.7 cells were transfected with empty vectors or plasm ids 
encoding the active catalytic subunit of Protein Kinase A (PKA cat-a). Following 
transfection, cells were exposed to ejther room air (RA) or sustained 0.1 % O2 
hypoxia (SH 0.1 %) for 24h. The mutant 123.7 cells transfected with PKA cat-a 
plasmids had higher levels of PKA activity than the vector controls under hypoxic 
conditions. Data expressed as the means of the counts per minute (CPM) of 5 
individual experiments (n=5), with error bars indicating standard deviations. Two-
way ANOVA, Tukey post hoc t-test, * p<.OO5 PKA cat a transfected cells vs. 
vector controls of the same oxygen condition. 
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Effect of PKA cat a transfection on hypoxia-induced ROS production and cell 
death: Transfection of 123.7 cells with an active catalytic subunit of PKA led to a 
significant increase in hypoxia induced ROS production at 24h relative to RA 
controls (Figure 37). However, WT cells still exhibited a larger increase in DCF 
fluorescence upon hypoxic challenge. Furthermore, the increase in ROS 
formation upon transfection in 123.7 cells did not result in a concomitant increase 
in cellular death, even after hypoxic challenge, as shown by Trypan Blue 
exclusion assays (Figure 38). Thus, although partially restoring PKA cat a in the 
123.7 cells increased ROS response to hypoxic challenge, the response was 
significantly below WT cell levels (Figure 37) and the resulting oxidative stress 
did not induce cell death. These data suggests that additional signaling events 
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Figure 37. Effect of PKA cat a Transfection on Hypoxia-induced ROS Levels 
PKA activity..cfeficient 123.7 cells were transfected with empty vectors or 
plasm ids encoding the active catalytic subunit of Protein Kinase A (PKA cat-a). 
WT and 123.7 cells were exposed to either room air (RA) or sustained 0.1 % 02 
hypoxia (SH 0.1%) for 24h. ROS levels, as detected by dichlorofluorescein 
(DCF) fluorescence, were significantly increased in WT cells following 24h of 
severe hypoxia, while 123.7 cells transfected with empty vectors experienced no 
significant alterations in DCF fluorescence. The mutant 123.7 cells transfected 
with PKA cat-a had a Significant increase in DCF fluorescence following hypoxic 
exposure, but these values were lower than WT cells. Data expressed as the 
means of relative fluorescence units (RFU) from 5 individual experiments (n=5), 
with error bars indicating standard deviations. Two-way ANOVA, Tukey post hoc 
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t-test, * p<.005 as indicated or PKA cat a transfected cells vs. vector controls of 
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Figure 38. Effect of PKA cat a Transfection on Hypoxia-induced Cell Death 
PKA activity-deficient 123.7 cells were transfected with empty vectors or 
plasmids encoding the active catalytic subunit of Protein Kinase A (PKA cat-a). 
WT and 123.7 cells were exposed to either room air (RA) or sustained 0.1 % O2 
hypoxia (SH 0.1 %) for 24h. Cell viability was assessed using the Trypan Blue 
exclusion assay. The number of live cells per well was Significantly decreased in 
WT cells following 24h of severe hypoxia, while transfected 123.7 cells had no 
change in the number of live cells. Data expressed as the means of 10 individual 
experiments (n=10), with error bars indicating standard deviations. Two-way 
ANOVA, Tukey post hoc t-test, * p<.05 RA 24h vs. SH 0.1 % 24h for one cell line. 
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Effect of PKA cat a transfection on hypoxia-induced metabolic response: 
Transfection of 123.7 cells with PKA cat a. did not significantly change 
extracellular pH (Figure 39), glucose consumption (Figure 40), lactate release 
(Figure 41), pyruvate release (Figure 42), or COX IV expression (Figure 43) 
relative to empty vector controls or untransfected cells. These findings suggest 
that increased PKA activity affects ROS levels, without altering cell metabolism. 
However, it can not be ruled out that prolonged PKA activation may be necessary 
for upregulation of metabolism to the levels seen in WT cells. Alternatively, a 
more sustained increase in ROS levels triggers metabolic responses which may 
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Figure 39. Effect of PKA cat a Transfection on Extracellular pH PKA 
activity-deficient 123.7 cells were transfected with empty vectors or plasm ids 
encoding the active catalytic subunit of Protein Kinase A (PKA cat-a.). WT and 
123.7 cells were exposed to either room air (RA) or sustained 0.1 % O2 hypoxia 
(SH 0.1%) for 24h. Both WT and transfected 123.7 cells had a drop in 
extracellular pH following 24h of hypoxic exposure. However, extracellular pH 
levels were higher in transfected 123.7 cells than in WT cells in both normoxic 
and hypoxic conditions. Transfection of the 123.7 cells with PKA cat-a had no 
effect on the extracellular pH levels relative to the vector-transfected 123.7 cells. 
Data expressed as the means of 10 individual experiments (n=10), with error 
bars indicating standard deviations. Two-way ANOVA, Tukey post hoc t-test, * 
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Figure 40. Effect of PKA cat a Transfection on Extracellular Glucose PKA 
activity-deficient 123.7 cells were transfected with empty vectors or plasm ids 
encoding the active catalytic subunit of Protein Kinase A (PKA cat-a). WT and 
123.7 cells were exposed to either room air (RA) or sustained 0.1 % O2 hypoxia 
(SH 0.1 %) for 24h. Extracellular glucose levels were significantly lower in WT 
cells than in transfected 123.7 cells following 24h of RA exposure. Hypoxic 
exposure enhanced these differences, with depletion of extracellular glucose 
stores in the WT cell line. Transfection of the 123.7 cells with PKA cat-a had no 
effect on the extracellular glucose levels relative to the vector-transfected 123.7 
cells. Data expressed as the means of 4-10 individual experiments (n=4-10), 
with error bars indicating standard deviations. Two-way AN OVA, Tukey post hoc 
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t-test, * p<.05 RA 24h vs. SH 0.1 % 24h for each condition, ** p<.001 as 
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Figure 41. Effect of PKA cat a Transfection on Extracellular Lactate PKA-
activity-deficient 123.7 cells were transfected with empty vectors or plasm ids 
encoding the active catalytic subunit of Protein Kinase A (PKA cat-a). 123.7 cells 
were exposed to either room air (RA) or sustained 0.1 % O2 hypoxia (SH 0.1 %) 
for 24h. Extracellular lactate was increased in the 123.7 cells following hypoxic 
exposure, but transfection of the 123.7 cells with PKA cat-a had no effect on the 
extracellular lactate levels relative to the vector-transfected 123.7 cells. Data 
expressed as the means of 5 individual experiments (n=5), with error bars 
indicating standard deviations. Two-way ANOVA, Tukey post hoc t-test, p s .001 
RA 24h vs. SH 0.1 % 24h for each condition. 
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Figure 42. Effect of PKA cat a Transfection on Extracellular Pyruvate PKA-
activity-deficient 123.7 cells were transfected with empty vectors or plasmids 
encoding the active catalytic subunit of Protein Kinase A (PKA cat-a). 123.7 cells 
were exposed to either room air (RA) or sustained 0.1 % 02 hypoxia (SH 0.1 %) 
for 24h. The 123.7 cells had significantly higher levels of extracellular pyruvate 
following hypoxic exposure, but transfection of the 123.7 cells with PKA cat-a. 
had no effect on the extracellular pyruvate levels relative to the vector transfected 
123.7 cells. Data expressed as the means of 5 individual experiments (n=5), with 
error bars indicating standard deviations. Two-way ANOVA, Tukey post hoc t-












Figure 43. Effect of PKA cat a transfection on COX IV expression PKA-
activity-deficient 123.7 cells were transfected with empty vectors or plasm ids 
encoding the active catalytic subunit of Protein Kinase A (PKA cat-a). Cells were 
exposed to either room air (RA) or sustained 0.1% 02 hypoxia (SH 0.1%) for 24h. 
The expression of cytochrome oxidase IV (COX IV) was analyzed and loading 
efficiency was confirmed through immunoblotting of f3-actin . The 123.7 cells had 
a decrease in COX IV expression after 24h of hypoxic exposure. Transfection of 
the 123.7 cells with PKA cat-a had no effect on the COX IV expression levels 
relative to the vector transfected 123.7 cells. Results representative of 5 
individual experiments (n=5). 
74 
Effect of PKA cat a transfection on energetic status: Transfection of 123.7 cells 
resulted in a small, but not statistically significant decrease in ATP levels (Figure 
44), likely due to the short serum deprivation called for by the transfection 
protocol. However, there was no significant difference in ATP levels between 
123.7 cells transfected with PKA cat a relative to empty vector controls (Figure 
44). Again, it can not be excluded that a longer PKA activation could trigger the 
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Figure 44. Effect of PKA cat a Transfection on ATP Levels PKA-activity-
deficient 123.7 cells were transfected with empty vectors or plasmids encoding 
the active catalytic subunit of Protein Kinase A (PKA cat-a). WT and 123.7 cells 
were exposed to either room air (RA) or sustained 0.1 % O2 hypoxia (SH 0.1 %) 
for 24h. ATP levels were significantly decreased in WT cells following 24h of 
hypoxic exposure, while 123.7 cells had no change in ATP levels. The 123.7 
cells also had a lower basal level of ATP than WT cells. Transfection of 123.7 
cells with PKA cat-a had no effect on the ATP levels relative to the vector-
transfected 123.7 cells or non-transfected 123.7 cells. Data expressed as the 
means of relative luminescence units (RLU) from 5-7 individual experiments 
(n=5-7), with error bars indicating standard deviations. Two-way ANOVA, Tukey 
post hoc !-test, * p<.005 RA 24h vs. SH 0.1 % 24h for each condition. 
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DISCUSSION 
Hypoxia is characterized by an inadequate oxygen supply to the tissues in 
proportion to their metabolic needs, and leads to an imbalance in energy 
production and cell death. While many hypoxic Signaling events have been 
elucidated, the role of the Protein Kinase A (PKA) has yet to be clarified. PKA 
has been attributed a function as both an anti-apoptotic kinase as well as a pro-
apoptotic signal. Thus the contribution of PKA to hypoxia-induced cell survival is 
currently unclear. 
In order to examine the role of the PKA pathway in hypoxia-induced 
signaling, I used a genetically altered line of PC-12 cells, 123.7 cells, which have 
a mutated PKA I regulatory subunit. I hypothesized, based on the current 
literature, that PKA activity regulates PC-12 hypoxic cell death via oxidative 
stress and cellular energy depletion. Specific Aim 1 was to determine whether 
PKA activity affects cellular tolerance to hypoxia and production of oxidant 
species. WT and 123.7 cells were exposed to either room air or sustained 0.1 % 
oxygen hypoxia for up to 24h. WT cells had significant cell death at 24h of 
sustained hypoxia, while the PKA-activity deficient 123.7 cells had no cell death 
at this time. This indicates that PKA activity contributes to hypoxia-induced cell 
death, supporting our hypothesis that PKA regulates PC-12 hypoxic cell death. 
77 
This supports earlier work, in which inhibitors of PKA were shown to have 
protective effects against ischemia-reperfusion injury in the rabbit heart (17). 
Activation of PKA has also been shown to be neuroprotective in a variety of 
neuronal models (31). 
A potential mechanism for PKA's deleterious effect in WT cells may 
involve PKA regulation of the mitochondrial chain enzymes. PKA has been 
shown to directly phosphorylate complexes I and IV of the mitochondrial electron 
transport chain (16,17). The phosphorylation of Complex I results in increased 
activity, while phosphorylation of Complex IV decreases its activity (16,17). 
Complexes I and III have been identified as potential ROS leakage sites in the 
mitochondrial electron transport chain (10). Therefore, the PKA-dependent 
increase in activity of Complex I and decreased activity of Complex IV may result 
in disruption of the electron flow and increased ROS leakage (16, 17). This may 
shift the redox balance of the cell towards a state of oxidative stress. 
Consequently, PKA activity may playa role in the modulation of hypoxia-induced 
oxidative stress and cellular death. 
Indeed, the onset of cell death in WT cells following 24 hours of severe, 
sustained hypoxia correlates with an increase in oxidative stress as shown by 
dichlorofluorescein (DCF) assays. In contrast, no such increase was detected in 
123.7 cells. These data support our hypothesis that PKA activity contributes to 
hypoxia-induced oxidative stress. Similar results have been found in rat 
macrophages and cardiomyocytes, in which PKA activity contributes to the 
formation of reactive oxygen species in the mitochondrial electron transport chain 
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(17,59). Interestingly, neither the GSH/GSSG ratio nor SOD-1 expression were 
altered in WT cells following hypoxia-induced oxidative stress. The absence of 
antioxidant response in these cells may indicate that the antioxidant systems in 
the PC-12 cell line are compromised at 24h. 
The effects of PKA on the function of antioxidant systems have not been 
well-characterized in the literature. The low levels of detected oxidative stress in 
123.7 cells could be due to upregulation of antioxidant systems, and thus 
enhanced detoxification of ROS. In the WT and 123.7 cells, there were no 
significant differences in the GSH/GSSG ratio, total glutathione levels, or SOO-1 
expression. Consequently, PKA activity does not appear to playa role in the 
regulation of ce"ular antioxidant mechanisms in our experimental model. This 
suggests that 123.7 cells have lower levels of hypoxia-induced ROS production, 
rather than increased detoxification abilities. 
Oxidative stress during hypoxia can directly lead to mitochondrial damage 
and interruption of energy production by the mitochondrial electron transport 
chain. Furthermore, during hypoxia, oxidative phosphorylation processes decline 
and cells must progressively rely on anaerobic metabolism. This can present an 
energy challenge for the cells, as glycolysis produces a net gain of only 2 ATP 
relative to the approximately 36-38 ATP that can be produced by oxidative 
phosphorylation and glycolytic processes combined. 
Specific Aim 2 was to determine whether PKA regulates hypoxia-induced 
cell death via oxidative stress and/or energy depletion. As expected, severe 
hypoxia decreased ATP levels by 24 hours in WT cells, indicating that hypoxic 
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exposure disrupts energy production. In contrast, 123.7 cells had a lower basal 
level of ATP that did not further decrease following 24 hours of hypoxic exposure. 
These data support our hypothesis that PKA activity regulates PC-12 cell death 
via cellular energy depletion. 
cAMP levels were also examined in these cells, as their mutated PKA 
regulatory subunit prevents binding of cAMP and could thus potentially alter 
cAMP levels within the cells and lead to changes in the energy pool. However, 
there was no alteration in cAMP levels between WT and 123.7 cells during 
normoxic or hypoxic incubation. This corroborates with earlier research showing 
that the mutation of PKA in 123.7 cells had no effect on cAMP levels (47). 
PKA inactivation may allow 123.7 cells to operate at a lower energy cost 
under both normoxic and hypoxic states. This, in addition to their low ROS 
levels, could provide a potential mechanism for their higher tolerance to hypoxic 
injury. It has been well characterized that hypoxia-tolerant reptiles are able to 
enter into a hypometabolic state and conserve energy (60, 61). Although it has 
been speculated that protein kinases are responsible for the adaptive signaling 
pathways, the role of PKA has yet to be clarified (60). It is possible, however, 
that the ROS induced by PKA activity may contribute to hypoxia-induced energy 
failure. 
In order to clarify the role of ROS in PC-12 cell death, WT and 123.7 cells 
were pre-treated with the antioxidant N-acetyl cysteine (NAC) one hour prior to 
their hypoxic exposure. N-acetyl cysteine treatment led to a drastic increase in 
the ratio of reduced/oxidized forms of glutathione under both normoxic and 
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hypoxic conditions. However, NAC treatment did not affect the total glutathione 
levels in either cell line, suggesting that the antioxidant may be directly acting as 
a reducing agent for the existing pool of glutathione, rather increasing generation 
of new glutathione. Although the antioxidant function of NAC was previously 
thought to be due solely to its role in glutathione biosynthesis, more recent work 
suggests that NAC can also directly detoxify ROS (62, 63, 64). 
Treatment of WT cells with NAC reduced ROS levels and improved cell 
survival, indicating that oxidative stress contributes to hypoxia-induced PC-12 
cell death. While preventing WT cell death, N-acetyl cysteine pre-treatment 
failed to restore ATP levels, suggesting that energy depletion during hypoxia may 
occur independently from oxidative stress. Alternatively, ROS production may be 
a consequence of metabolic change, occurring downstream of these changes 
and resulting in cell death. However, in chemical models of hypoxia, antioxidant 
treatment was found in PC-12 cells to restore ATP levels following administration 
of cyanide (65). Thus the effect of antioxidant treatment on energy depletion 
may depend on the type and severity of hypoxic insult, or the antioxidant used. 
Specific Aim 3 was to determine whether PKA affects cellular energetic 
status through regulation of metabolic pathways. PKA has also been linked to 
the control of the glycolytic rate limiting enzyme, phosphofructokinase, 
implicating PKA in the regulation of glucose metabolism (35,36). HIF-1 a, a 
hypoxia-regulated transcription factor, recognizes and binds the hypoxia 
response element, activating transcription of a wide variety of genes. Among 
these genes are also several glucose transporters and multiple glycolytic 
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enzymes. Increased HIF-1 a dependent transcription may provide energy 
resources allowing the cells to cope with the hypoxic stress. HIF-1 a protein 
stability and its ability to bind DNA are controlled by phosphorylation and by 
hydroxyprolination, and requires PKA-dependent transcription factors binding as 
co-activators for transcriptional activation (6,37,38). Thus, in addition to its effects 
on oxidative stress, PKA may modulate cellular survival to hypoxia through 
regulation of metabolic pathways. 
To determine whether mitochondrial function is differentially affected by 
hypoxia in these two cell types, changes in mitochondrial membrane potential 
were assessed using JC-1, a fluorescent probe sensitive to changes in 
mitochondrial membrane potential. WT and 123.7 cells exhibited similar 
mitochondrial membrane potentials under normoxic states and both cell types 
showed a trend of decrease in JC-1 ratio upon hypoxic exposure. However, 
overall mean normoxic and hypoxic JC-1 ratios were in higher in 123.7 cells than 
in WT cells. These data may indicate that PKA has an inhibitory effect on 
mitochondrial metabolism and contributes to the loss of mitochondrial membrane 
potential. In cardiomyocytes, the addition of exogenous PKA cat-a leads to a 
loss of the mitochondrial membrane potential (59). 
However, in cardiomyocytes, the actions of PKA cat-a on mitochondrial 
membrane potential were blocked by administration of an antioxidant (Nagasaki, 
2007). Antioxidant treatment was also found in PC-12 cells to restore 
mitochondrial membrane potential following cyanide treatment (65). In our 
experimental conditions, antioxidant treatment had no effect on the mitochondrial 
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membrane potential. Thus it appears that the mechanism by which PKA controls 
mitochondrial function may differ according to the cell line and the extent and 
type of hypoxic insult. 
To further examine the effect of PKA activity on mitochondrial function, the 
expression of cytochrome oxidase (COX IV) was examined. COX IV is the last 
enzymatic complex in the mitochondrial electron transport chain. Hypoxia 
decreases the Vmax of cytochrome oxidase, resulting in production of ROS due to 
the improper flow of electrons and leakage of oxidant radically mainly at the 
levels of Complexes I and III (14, 15). COX IV expression was significantly 
higher in 123.7 cells relative to WT cells during both RA and SH, suggesting 
either an increase in mitochondrial enzyme or in mitochondrial number with PKA 
inactivation. As expected, COX IV expression was decreased upon hypoxic 
exposure in both cell types. Antioxidant treatment had no effect on COX IV 
expression in either cell type, indicating that ROS levels do not directly affect 
COX IV expression in our experimental model. 
COX IV activity may still be sufficient in 123.7 cells, despite the lower 
oxygen levels, to allow the flow of electrons through the mitochondrial 
complexes. Additionally, in the absence of PKA activity, downregulation of COX 
IV activity by PKA phosphorylation may not occur. This could allow 123.7 cells to 
maintain mitochondrial energy production even under drastically reduced oxygen 
conditions, and increase their ability to maintain electron flow through the 
mitochondrial transport chain without electron leakage and ROS production. 
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Maintenance of low levels of COX IV activity under hypoxic conditions has been 
observed in hypoxia-tolerant model systems (66). 
HIF-1 ex, whose stabilization is influenced by PKA-dependent transcription 
factors, contributes to the shift from aerobic to anaerobic metabolism under 
hypoxic states. Additionally, hypoxia-induced ROS production has been shown 
to be necessary for stabilization of HIF-1 ex (67). In the PKA activity deficient 
123.7 cell line, HIF-1 signaling may be depressed, leading to disruption of this 
metabolic shift. This could explain the ability of 123.7 cells to maintain a low 
level of aerobic metabolism under hypoxic conditions. 
In normally functioning cells, as COX IV expression and/or activity 
decreases under hypoxic conditions, cells must progressively rely on anaerobic 
metabolism for energy production. Glucose is quickly used within the cell to 
produce ATP via enhanced glycolytic activity. I have shown here that glucose 
levels in the media do significantly drop upon hypoxic exposure in both cell types. 
However, this decrease was much larger in the WT cells, which had negligible 
levels of extracellular glucose following 24h of hypoxic exposure. The 123.7 cells 
had higher levels of extracellular glucose at both RA and SH, indicating a lower 
glycolytic flux. This further indicates that PKA activity facilitates the hypoxia-
induced metabolic shift from aerobic to anaerobic metabolism. The 123.7 cells 
appear to continue aerobic metabolism for a longer period of time than WT cells 
under hypoxic stress, allowing for more efficient ATP production, and potentially 
protecting them from hypoxia-induced cell death. 
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WT and 123.7 cells had a drop in extracellular pH following hypoxic 
exposure, which is likely due to the efflux of lactate from the cell and/or the 
release of acidic cellular contents. Intracellular acidification may upregulate 
activity of the Na + /H+ exchanger, but this process is likely limited by the 
accumulation of extracellular lactate surrounding the membrane (58). It has 
been shown in sheep purkinje fibers that inhibition of the Na +/H+ exchanger had 
no significant effect on extracellular acidification following hypoxic exposure (58). 
Hypoxia-induced decreases in pH were not affected by N-acetyl cysteine 
treatment, despite the fact that antioxidant treatment rescues WT cells. This 
suggests that hypoxia-induced decreases in extracellular pH may be primarily 
due to the release of lactate rather than from the release of acidic content from 
dying cells. 
Indeed, extracellular lactate levels did increase in both WT and 123.7 cells 
after hypoxic exposure. WT cells, however, exhibited higher levels of lactate 
release under both normoxic and hypoxic conditions, in accordance with their 
increased glucose utilization, indicating that PKA activity enhances the 
production and/or release of lactate from cells. Additionally, WT cells exhibited 
higher extracellular pyruvate levels under normoxic conditions, but were 
unaffected by hypoxic exposure. The 123.7 cells displayed an increase in 
extracellular pyruvate upon hypoxic challenge. PKA has been shown to be 
necessary for the stabilization of lactate dehydrogenase mRNA (68). This 
complete inactivation of PKA activity in 123.7 cells may prevent the efficient 
conversion of lactate to pyruvate. 
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PKA could upregulate glycolytic flux during hypoxia directly through 
enzymatic control, or indirectly due to the production of oxidant species. 
However, antioxidant treatment with N-acetyl cysteine had no effect on 
extracellular glucose values, suggesting that ROS do not contribute to 
upregulation of glycolytic flux under hypoxic conditions. Furthermore, treatment 
with N-acetyl cysteine did not affect lactate or pyruvate values, once again 
indicating that oxidative stress does not alter glycolytic rate. Thus, the effect of 
PKA on glycolytic flux appears to occur directly through regulation of enzymatic 
activity, rather than ROS production. 
The PKA signaling pathway plays many vital roles in the cell. The majority 
of knockout mice containing a null mutation in the PKA catalytic a subunit 
experience early postnatal lethality (69). Those mice that do survive have 
upregulation of the PKA catalytic p subunit (69). Since PKA activity is minimal in 
the 123.7 PC-12 cell line, compensations may have occurred in order for them to 
remain viable. For Specific Aim 4, I wanted to determine whether restoration of 
PKA activity in the 123.7 cells would abrogate differences in hypoxic 
susceptibility and energy homeostasis between WT and 123.7 cells. The 123.7 
cells were transfected with plasmids encoding active PKA catalytic a subunits to 
restore PKA activity in these cells. Over-expression of PKA cat a was verified by 
Western blotting and PKA activity assays. 
Transfection of 123.7 cells with an active catalytic a subunit of PKA 
increased ROS levels upon hypoxic exposure, albeit to a level less than that 
seen in WT cells. This finding confirms that PKA activity is necessary for the 
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onset of oxidative stress under hypoxic conditions in our experimental model. 
However, the oxidative stress in transfected 123.7 cells did not appear to be 
significant enough to cause hypoxic cell death. This finding indicates that 
oxidative stress may lead to cell death in a dose-dependent manner, and that 
PKA transfection in 123.7 cells did not reach a threshold of oxidative stress 
necessary for induction of death. 
Furthermore, transfection of 123.7 cells with an active catalytic subunit of 
PKA did not appear to affect metabolic variables such as extracellular pH, 
glucose, lactate, or pyruvate levels. Similarly, intracellular ATP levels were not 
significantly altered relative to empty vector controls. This indicates that transient 
transfection of PKA cat a into 123.7 cells may not be sufficient to induce 
upregulation and maintenance of the high metabolic rate seen in WT cells. 
Conversely, metabolic adaptations may have occurred in 123.7 cells following 
prolonged PKA inactivation that may prevent efficient upregulation of metabolic 
processes following re-activation of the pathway. 
In conclusion, the experiments which I have performed support my original 
hypothesis that PKA activity regulates PC-12 hypoxic cell death via oxidative 
stress (Figure 45). PKA activity appears to contribute to hypoxia-induced cell 
death via enhanced production of ROS, but does not appear to playa role in the 
regulation of cellular antioxidant mechanisms. The role of PKA in hypoxia-
induced oxidative stress was confirmed through transfection studies in which 
restoration of PKA activity in the 123.7 cells increased their production of ROS. 
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Hypoxia also leads to a decrease in mitochondrial potential, COX IV 
expression, and ATP levels, all of which appear to be PKA-activity dependent. 
On the other hand, PKA activity increases glycolytic flux in PC-12 cells, 
particularly under periods of hypoxia. PKA thus appears to affect cellular 
energetic status through regulation of metabolic pathways. However, I was 
unable to confirm the role of PKA in these processes through the transfection 
studies. Prolonged PKA activation may be necessary for upregulation of 
metabolism to the levels seen in WT cells. Alternatively, a more sustained 
increase in ROS levels may trigger metabolic responses which are induced by 
HIF-1 a or NF-KB transcriptional activation (43). 
This work dictates a need for further examination into the role of PKA in 
the hypoxic response, and identification of cellular targets that could be used to 
disrupt the deleterious effects of PKA under hypoxic states. Modulation of the 
PKA signaling pathway could thus be used as a novel therapeutic strategy to 
improve cellular adaptation and recovery in the many pathologies characterized 









Figure 45: The Role of Protein Kinase A in Hypoxia-Induced PC-12 
Cell Death I have confirmed that the PKA signaling pathway 
contributes to hypoxia-induced PC-12 cell death through the production 
of reactive oxygen species. It was also shown that oxidative stress 
contributes to cell death independently of energy depletion in PC-12 
cells. I was unable to confirm, however, the role of PKA in hypoxia-
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